Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 464-471

  Sis, B ^a   Mengel, M ^a   Haas, M ^b   Colvin, R B ^c   Halloran, P F ^a   Racusen, L C ^d   Solez, K ^a   Baldwin III, W M ^e   Bracamonte, E R ^f   Broecker, V ^g   Cosio, F ^h   Demetris, A J ⁱ   Drachenberg, C ^j   Einecke, G ^g   Gloor, J ^h   Glotz, D ^k   Kraus, E ^d   Legendre, C ^l   Liapis, H ^m   Mannon, R B ⁿ   Nankivell, B J ^o   Nickeleit, V ^p   Papadimitriou, J C ^j   Randhawa, P ⁱ   Regele, H ^q   Renaudin, K ^r   Rodriguez, E R ^e   Seron, D ^s   Seshan, S ^t   Suthanthiran, M ^u   Wasowska, B A ^d   Zachary, A ^d   Zeevi, A ⁱ   more..

^a UNIVERSITY OF ALBERTA   (Canada)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Mayo Foundation and Clinic   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^k SAINT LOUIS HOSPITAL   (France)

^l UNIVERSITÉ PARIS DESCARTES   (France)

^m WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ University of Alabama at Birmingham   (United States)

^o WESTMEAD HOSPITAL   (Australia)

^p UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF VIENNA   (Austria)

^r HÔTEL DIEU   (France)

^s HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^t NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^u WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

Acute allograft rejection; Acute cellular rejection; Acute rejection; Allograft rejection; Antibody mediated rejection; Banff; Banff lesions; Banff schema; Chronic allograft rejection; Classification; Donor specific antibody; GeneChip; Genomic markers

Indexed keywords

COMPLEMENT COMPONENT C4D; FC RECEPTOR; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; CLINICAL RESEARCH; CONFERENCE PAPER; ENDOTHELIUM; FIBROSING ALVEOLITIS; GLOMERULOPATHY; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; KIDNEY TRANSPLANTATION; MORBIDITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE FUNCTION; VASCULAR DISEASE; BIOPSY; CANADA; CHEMISTRY; FIBROSIS; KIDNEY DISEASES; METABOLISM; MULTICENTER STUDY (TOPIC); PATHOLOGY; PHENOTYPE; POLYOMAVIRUS INFECTIONS; PROCEDURES; QUALITY CONTROL; VIROLOGY;

ANTIBODIES; BIOPSY; CANADA; COMPLEMENT C4B; FIBROSIS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES AS TOPIC; ORGAN TRANSPLANTATION; PEPTIDE FRAGMENTS; PHENOTYPE; POLYOMAVIRUS INFECTIONS; QUALITY CONTROL;

EID: 75749119257     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02987.x     Document Type: Conference Paper

References (49)

1. Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966 2 : 662 665.
2. Morris PJ, Williams GM, Hume DM, Mickey MR, Terasaki PI. Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplant 1968 6 : 392 399.
3. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplant 1990 49 : 85 91.
4. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplant 1992 53 : 550 555.
5. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991 86 : 464 470.
6. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574 582.
7. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002 13 : 2371 2380.
8. Uehara S, Chase CM, Cornell LD, Madsen JC, Russell PS, Colvin RB. Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 2007 7 : 57 65.
9. Minami K, Murata K, Lee CY et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006 6 (5 Pt 1 923 932.
10. Hirohashi T, Uehara S, Chase CM, Madsen JC, Russell PS, Colvin RB. Antibody mediated, complement independent transplant arteriopathy in mice. Am J Transplant 8 (Suppl 2), 179 180. 1-5-2008.
11. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM, III., Wasowska BA. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004 4 : 326 334.
12. Murata K, Fox-Talbot K, Qian Z et al. Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants. Am J Transplant 2007 7 : 2605 2614.
13. Locke JE, Zachary AA, Warren DS et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant 2009 9 : 2136 2139.
14. Breimer ME, Rydberg L, Jackson AM et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplant 2009 87 : 549 556.
15. Lachmann N, Terasaki PI, Budde K et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplant 2009 87 : 1505 1513.
16. Morales-Buenrostro LE, Castro R, Terasaki PI. A single human leukocyte antigen-antibody test after heart or lung transplantation is predictive of survival. Transplant 2008 85 : 478 481.
17. Burns JM, Cornell LD, Perry DK et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008 8 : 2684 2694.
18. Rother RP, Arp J, Jiang J et al. C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients. Am J Transplant 2008 8 : 1129 1142.
19. Michaels PJ, Fishbein MC, Colvin RB. Humoral rejection of human organ transplants. Springer Semin Immunopathol 2003 25 : 119 140.
20. Tan CD, Sokos GG, Pidwell DJ et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009 9 : 2075 2084.
21. Stewart S, Winters GL, Fishbein MC et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005 24 : 1710 1720.
22. Sis B, Jhangri G, Bunnag S, Allanach K, Kaplan B, Halloran PF. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009 9 : 2312 2323.
23. Nimmerjahn F, Anthony RM, Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 2007 104 : 8433 8437.
24. Yamakuchi M, Kirkiles-Smith NC, Ferlito M et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 2007 104 : 1301 1306.
25. Lee CY, Lotfi-Emran S, Erdinc M et al. The involvement of FcR mechanisms in antibody-mediated rejection. Transplant 2007 84 : 1324 1334.
26. Macgregor A, Fox-Talbot K, Velidedeoglu E, Baldwin WMI, Wasowska BA. The absence of FcRIII results in increased pro-inflammatory response in FcRIII KO cardiac allograft recipients. Am J Transplant 2009 9 (Suppl 2) : 481.
27. Morrell CN, Murata K, Swaim AM et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res 2008 102 : 777 785.
28. Fukami N, Ramachandran S, Saini D et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009 182 : 309 318.
29. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007 7 : 1743 1752.
30. Gloor JM, Sethi S, Stegall MD et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007 7 : 2124 2132.
31. Haas M, Montgomery RA, Segev DL et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007 7 : 576 585.
32. Sis B, Reeve J, Einecke G et al. Endothelial stress accelerates graft loss in kidneys with transplant glomerulopathy despite lack of C4D staining. Am J Transplant 2009 9 (Suppl 2 349.
33. Wavamunno MD, O'Connell PJ, Vitalone M et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007 7 : 2757 2768.
34. Haas M, Segev DL, Racusen LC et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009 20 : 197 204.
35. Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
36. Mannon RB. Therapeutic targets in the treatment of allograft fibrosis. Am J Transplant 2006 6 : 867 875.
37. Mengel M, Reeve J, Bunnag S et al. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2009 9 : 169 178.
38. El Zoghby ZM, Stegall MD, Lager DJ et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009 9 : 527 535.
39. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009 9 : 2520 2531.
40. Reeve J, Einecke G, Mengel M et al. Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant 2009 9 : 1802 1810.
41. Kayler LK, Kiss L, Sharma V et al. Acute renal allograft rejection: Diagnostic significance of focal peritubular capillary C4d. Transplant 2008 85 : 813 820.
42. Kedainis RL, Koch MJ, Brennan DC, Liapis H. Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am J Transplant 2009 9 : 812 819.
43. Mengel M, Reeve J, Bunnag S et al. Scoring total inflammation is superior to the current banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009 9 : 1859 1867.
44. Sis B, Dadras F, Khoshjou F, Cockfield S, Mihatsch MJ, Solez K. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006 6 : 1444 1450.
45. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008 8 : 753 760. (Pubitemid 351347767)
46. Anglicheau D, Loupy A, Pessione F et al. A simple clinico- histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 2008 8 : 2325 2334.
47. Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 7 : 2712 2722.
48. Drachenberg CB, Papadimitriou JC, Hirsch HH et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004 4 : 2082 2092.
49. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723. (Pubitemid 29082898)